150 related articles for article (PubMed ID: 10715701)
1. The community-directed, ivermectin-treatment programme for onchocerciasis control in Uganda--an evaluative study (1993-1997).
Katabarwa M; Mutabazi D; Richards F
Ann Trop Med Parasitol; 1999 Oct; 93(7):727-35. PubMed ID: 10715701
[TBL] [Abstract][Full Text] [Related]
2. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Katabarwa MN; Habomugisha P; Richards FO
Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803
[TBL] [Abstract][Full Text] [Related]
3. Controlling onchocerciasis by community-directed, ivermectin-treatment programmes in Uganda: why do some communities succeed and others fail?
Katabarwa NM; Mutabazi D; Richards FO
Ann Trop Med Parasitol; 2000 Jun; 94(4):343-52. PubMed ID: 10945044
[TBL] [Abstract][Full Text] [Related]
4. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1998 Dec; 92(8):859-68. PubMed ID: 10396346
[TBL] [Abstract][Full Text] [Related]
5. Community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda: the selection and validation of indicators for monitoring sustainability at the district level.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1999 Sep; 93(6):653-8. PubMed ID: 10707110
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
[TBL] [Abstract][Full Text] [Related]
7. The challenge of establishing community-directed treatment with Mectizan in Uganda.
Okwero P
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
[TBL] [Abstract][Full Text] [Related]
8. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
[TBL] [Abstract][Full Text] [Related]
9. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826
[TBL] [Abstract][Full Text] [Related]
10. Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda.
Katabarwa MN; Richards FO
Ann Trop Med Parasitol; 2001 Apr; 95(3):275-86. PubMed ID: 11339887
[TBL] [Abstract][Full Text] [Related]
11. Onchocerciasis control in Uganda: how can self-sustaining, community-based treatment with ivermectin be achieved?
Mutabazi D; Duke BO
Ann Trop Med Parasitol; 1998 Mar; 92(2):195-203. PubMed ID: 9625916
[TBL] [Abstract][Full Text] [Related]
12. Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions--a comparison of Cameroon and Uganda experiences over a period of three years (2004-2006).
Katabarwa M; Habomugisha P; Eyamba A; Agunyo S; Mentou C
Trop Med Int Health; 2010 Feb; 15(2):216-23. PubMed ID: 20002616
[TBL] [Abstract][Full Text] [Related]
13. Using ivermectin-treatment coverage among schoolchildren monitored by schoolteachers as a proxy of population coverage in areas of Uganda where onchocerciasis is endemic.
Ndyomugyenyi R; Remme J
Ann Trop Med Parasitol; 2002 Jan; 96(1):53-60. PubMed ID: 11989535
[TBL] [Abstract][Full Text] [Related]
14. Ivermectin distribution using community volunteers in Kabarole district, Uganda.
Kipp W; Burnham G; Bamuhiiga J; Weis P; Büttner DW
Health Policy Plan; 1998 Jun; 13(2):167-73. PubMed ID: 10180405
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria.
Onowhakpor AO; Okojie OH; Wagbatsoma VA
Indian J Public Health; 2017; 61(4):267-273. PubMed ID: 29219132
[TBL] [Abstract][Full Text] [Related]
16. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2018 Jun; 11(1):356. PubMed ID: 29921312
[TBL] [Abstract][Full Text] [Related]
17. Onchocerciasis control in Nigeria: will households be able to afford community-directed treatment with ivermectin?
Onwujekwe O; Shu E; Onwuameze O; Ndum C; Okonkwo P
Acta Trop; 2001 Dec; 80(3):277-81. PubMed ID: 11700186
[TBL] [Abstract][Full Text] [Related]
18. In rural Ugandan communities the traditional kinship/clan system is vital to the success and sustainment of the African Programme for Onchocerciasis Control.
Katabarwa NM; Richards FO; Ndyomugyenyi R
Ann Trop Med Parasitol; 2000 Jul; 94(5):485-95. PubMed ID: 10983561
[TBL] [Abstract][Full Text] [Related]
19. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda.
Sama MT; Homeida M; Ngang P; Liese BH; Amazigo U; Seketeli A
Trop Doct; 2003 Oct; 33(4):237-41. PubMed ID: 14620432
[TBL] [Abstract][Full Text] [Related]
20. Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
Amazigo U; Noma M; Boatin BA; Etya'alé DE; Sékétéli A; Dadzie KY
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S23-31. PubMed ID: 9861264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
